Form 4 for SRPT Sarepta Therapeutics, Inc.
Accepted 2021-11-17 00:00:00 ET · period of report 2021-11-16 · accession 0001209191-21-065314 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-11-17 | 2021-11-16 | SRPT | Rodino-Klapac Louise | CSO | A - Grant | $0.00 | +40.0K | 61.9K | +183% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-16 | A | A | 40,000 | $0.00 | 61,898 | D | — | — | (F1) The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date. (F2) The amount of securities directly owned by the reporting person includes 118 shares of common stock purchased under the Company's Amended and Restated 2013 Employee Stock Purchase Plan on August 31, 2021. |